Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Persuasion Strategies01:52

Persuasion Strategies

43.0K
Researchers have tested many persuasion strategies, including the foot-in-the door and the door-in-the-face techniques, in a variety of contexts. Ultimately, the principles are effective in selling products and changing people’s attitude, ideas, and behaviors (Cialdini & Goldstein, 2004).
43.0K
Coping Strategies: Problem Focused01:27

Coping Strategies: Problem Focused

445
Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...
445
Strategies of Self-Presentation II: Self-Verification01:17

Strategies of Self-Presentation II: Self-Verification

175
Self-verification is a fundamental psychological drive wherein individuals seek affirmation of their self-concept from others, striving for consistency between their internal self-view and external perceptions. This drive operates even when the self-concept is negative, influencing interpersonal behavior and feedback preferences in complex and often counterintuitive ways. Unlike the self-enhancement motive, which seeks positive evaluations, self-verification prioritizes coherence and...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming Stars #17: Breaking Down the Barriers of Direct Reprogramming Using a Model Organism-An Interview with Dr. Baris Tursun.

Cellular reprogramming·2024
Same author

Identifying Molecular Roadblocks for Transcription Factor-Induced Cellular Reprogramming In Vivo by Using <i>C. elegans</i> as a Model Organism.

Journal of developmental biology·2023
Same author

Disintegration of the NuRD Complex in Primary Human Muscle Stem Cells in Critical Illness Myopathy.

International journal of molecular sciences·2023
Same author

SUMOylation of the chromodomain factor MRG-1 in <i>C. elegans</i> affects chromatin-regulatory dynamics.

BioTechniques·2022
Same author

Robust co-immunoprecipitation with mass spectrometry for <i>Caenorhabditis elegans</i> using solid-phase enhanced sample preparation.

BioTechniques·2022
Same author

Induced Neurons From Germ Cells in <i>Caenorhabditis elegans</i>.

Frontiers in neuroscience·2021

Related Experiment Video

Updated: Jan 22, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.5K

Strategies for in vivo reprogramming.

Andreas Ofenbauer1, Baris Tursun1

  • 1Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.

Current Opinion in Cell Biology
|July 20, 2019
PubMed
Summary
This summary is machine-generated.

In vivo reprogramming converts cell identities within living organisms for regenerative medicine. This review covers transcription factors, cell fusion, and small molecules for tissue repair, discussing barriers and delivery strategies.

More Related Videos

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

13.0K
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

10.0K

Related Experiment Videos

Last Updated: Jan 22, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.5K
In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

13.0K
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

10.0K

Area of Science:

  • Cell Biology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Cellular reprogramming offers potential for regenerative medicine by generating specific cell types.
  • Tissue regeneration aims to replace cells lost due to degenerative diseases or injury.
  • In vivo reprogramming directly converts cell identities within a living organism.

Purpose of the Study:

  • To review the latest strategies and advances in in vivo reprogramming.
  • To discuss methods for converting cell identities in living organisms.
  • To highlight challenges and delivery methods for in vivo reprogramming.

Main Methods:

  • Review of current literature on in vivo reprogramming techniques.
  • Discussion of reprogramming induced by transcription factors (TFs) and synthetic TFs (CRISPR/dCas9).
  • Exploration of cell fusion and small molecule-induced reprogramming.

Main Results:

  • In vivo reprogramming utilizes TFs, synthetic TFs, cell fusion, and small molecules.
  • Reprogramming efficiency is influenced by cellular senescence and inherent barriers.
  • Various strategies exist for delivering reprogramming factors in vivo.

Conclusions:

  • In vivo reprogramming is a promising avenue for regenerative medicine.
  • Overcoming reprogramming barriers and optimizing delivery are key for clinical translation.
  • Further research into senescence and advanced delivery systems will enhance therapeutic applications.